Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of Trastuzumab-induced Cardiotoxicity in Breast Cancer Patients
TCTR20210209001Recruiting
- Sponsor
- Chiang Mai University
- Start
- Oct 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Single-arm trial of trastuzumab in breast cancer, sponsored by Chiang Mai University. Primary endpoints: Incidence of trastuzumab-induced cardiotoxicity and Predictive factors for cardiotoxicity. Started Oct 2020; status: recruiting.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on TCTR20210209001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210209001.